HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mechanisms involving Ang II and MAPK/ERK1/2 signaling pathways underlie cardiac and renal alterations during chronic undernutrition.

AbstractBACKGROUND:
Several studies have correlated protein restriction associated with other nutritional deficiencies with the development of cardiovascular and renal diseases. The driving hypothesis for this study was that Ang II signaling pathways in the heart and kidney are affected by chronic protein, mineral and vitamin restriction.
METHODOLOGY/PRINCIPAL FINDINGS:
Wistar rats aged 90 days were fed from weaning with either a control or a deficient diet that mimics those used in impoverished regions worldwide. Such restriction simultaneously increased ouabain-insensitive Na+-ATPase and decreased (Na++K+)ATPase activity in the same proportion in cardiomyocytes and proximal tubule cells. Type 1 angiotensin II receptor (AT1R) was downregulated by that restriction in both organs, whereas AT2R decreased only in the kidney. The PKC/PKA ratio increased in both tissues and returned to normal values in rats receiving Losartan daily from weaning. Inhibition of the MAPK pathway restored Na+-ATPase activity in both organs. The undernourished rats presented expanded plasma volume, increased heart rate, cardiac hypertrophy, and elevated systolic pressure, which also returned to control levels with Losartan. Such restriction led to electrical cardiac remodeling represented by prolonged ventricular repolarization parameters, induced triggered activity, early after-depolarization and delayed after-depolarization, which were also prevented by Losartan.
CONCLUSION/SIGNIFICANCE:
The mechanisms responsible for these alterations are underpinned by an imbalance in the PKC- and PKA-mediated pathways, with participation of angiotensin receptors and by activation of the MAPK/ERK1/2 pathway. These cellular and molecular alterations culminate in cardiac electric remodeling and in the onset of hypertension in adulthood.
AuthorsPaulo A Silva, Gustavo Monnerat-Cahli, Amaury Pereira-Acácio, Ricardo Luzardo, Luzia S Sampaio, Marcia A Luna-Leite, Lucienne S Lara, Marcelo Einicker-Lamas, Rogério Panizzutti, Caroline Madeira, Leucio D Vieira-Filho, Carmen Castro-Chaves, Valdilene S Ribeiro, Ana D O Paixão, Emiliano Medei, Adalberto Vieyra
JournalPloS one (PLoS One) Vol. 9 Issue 7 Pg. e100410 ( 2014) ISSN: 1932-6203 [Electronic] United States
PMID24983243 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Angiotensin II Type 1 Receptor Blockers
  • Cation Transport Proteins
  • Receptor, Angiotensin, Type 2
  • Angiotensin II
  • Cyclic AMP-Dependent Protein Kinases
  • Protein Kinase C
  • Adenosine Triphosphatases
  • sodium-translocating ATPase
  • Sodium-Potassium-Exchanging ATPase
  • Losartan
Topics
  • Adenosine Triphosphatases (metabolism)
  • Angiotensin II
  • Angiotensin II Type 1 Receptor Blockers (pharmacology)
  • Animals
  • Blood Pressure
  • Cardiomegaly (pathology)
  • Cation Transport Proteins (metabolism)
  • Cyclic AMP-Dependent Protein Kinases (metabolism)
  • Heart (physiopathology)
  • Heart Rate
  • Kidney Tubules, Proximal (metabolism)
  • Losartan (pharmacology)
  • MAP Kinase Signaling System
  • Male
  • Malnutrition (metabolism)
  • Myocytes, Cardiac (metabolism)
  • Plasma Volume
  • Protein Kinase C (metabolism)
  • Rats
  • Rats, Wistar
  • Receptor, Angiotensin, Type 2 (metabolism)
  • Sodium-Potassium-Exchanging ATPase (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: